See the latest news and media coverage for Pfizer. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biopharmaceutical company
pfizer.comLast updated
In short: Pfizer reported first-quarter earnings beats, advanced its obesity pipeline, and faced litigation regarding the contraceptive Depo-Provera.
The partnership aims to accelerate R&D of 12 early-stage oncology programs, including ADCs and multi-specific antibodies, combining Pfizer's global expertise with Innovent's discovery capabilities.
The company emphasizes its commitment to patients and delivering breakthroughs that change lives.
The study involves a potential first-in-class IL4/13 and TSLP trispecific antibody for atopic dermatitis. It supports advancing a broad program for Type 2 inflammatory conditions.
The company delivered patient-changing breakthroughs and anticipates 2026 with focus and commitment.
Pfizer (PFE) stock drops as CFO Dave Denton will resign Aug. 15; Cecile Guegan is named interim CFO as the company launches an executive search.
The plaintiffs in the multidistrict litigation accusing Pfizer of failing to warn consumers of a link between brain tumors and the hormonal contraceptive Depo-Provera have...
Arvinas, Pfizer & Rigel’s Veppanu licensing deal is now active after U.S. antitrust clearance—$70M upfront plus up to $320M milestones.
Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Altria Group, Inc. (MO) and Newmont Corp. (NEM), as well...
Track Pfizer and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Pfizer and other trending companies.